Outcome | Baseline_risk |
---|---|
Adverse_event | 1.5% |
Hypoglycemia | 2.4% |
Stroke | 1.5% |
MI | 6.1% |
Hba1c | −1.01 |
Body_weight | −0.09 |
Injection | 0 |
Daily_glucose_testing | 3 |
Cost | 10 |
Nephropathy | 5.2% |
Retinopathy | 7.8% |
Neuropathy | 6.6% |
Outcome | Baseline_risk |
---|---|
Adverse_event | 1.5% |
Hypoglycemia | 2.4% |
Stroke | 1.5% |
MI | 6.1% |
Hba1c | −1.01 |
Body_weight | −0.09 |
Injection | 0 |
Daily_glucose_testing | 3 |
Cost | 10 |
Nephropathy | 5.2% |
Retinopathy | 7.8% |
Neuropathy | 6.6% |